Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Quoix

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|May 2, 2016
Post-operative survival of patients with lung cancerElisabeth Quoix
Therapeutic Advances in Medical Oncology|September 4, 2012
Therapeutic options in older patients with metastatic non-small cell lung cancerElisabeth Quoix
Oncotargets and Therapy|December 4, 2010
Topotecan in the treatment of relapsed small cell lung cancerElisabeth Quoix
Drugs & Aging|November 8, 2011
Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancerElisabeth Quoix
La Revue Du Praticien|June 21, 2007
[Recent development of the standards of treatment of lung cancer]Elisabeth Quoix
La Revue Du Praticien|October 21, 2009
[What is new in the epidemiology of lung cancer: non-smokers, women and the role of cannabis?]Elisabeth Quoix
La Revue Du Praticien|July 26, 2003
[Lung carcinoma]Elisabeth Quoix
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
Prognostic factors for survival in extensive stage small cell lung cancerElisabeth Quoix
Revue De Pneumologie Clinique|January 24, 2007
[Use of tyrosine kinase inhibitors in particular situations]Elisabeth Quoix
Lancet (London, England)|December 17, 2016
Programmed death of chemotherapy in non-small-cell lung cancer?Charlotte Leduc, Elisabeth Quoix
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|May 2, 2016
Post-operative survival of patients with lung cancerElisabeth Quoix
Therapeutic Advances in Medical Oncology|September 4, 2012
Therapeutic options in older patients with metastatic non-small cell lung cancerElisabeth Quoix
Oncotargets and Therapy|December 4, 2010
Topotecan in the treatment of relapsed small cell lung cancerElisabeth Quoix
Drugs & Aging|November 8, 2011
Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancerElisabeth Quoix
La Revue Du Praticien|June 21, 2007
[Recent development of the standards of treatment of lung cancer]Elisabeth Quoix
La Revue Du Praticien|October 21, 2009
[What is new in the epidemiology of lung cancer: non-smokers, women and the role of cannabis?]Elisabeth Quoix
La Revue Du Praticien|July 26, 2003
[Lung carcinoma]Elisabeth Quoix
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
Prognostic factors for survival in extensive stage small cell lung cancerElisabeth Quoix
Revue De Pneumologie Clinique|January 24, 2007
[Use of tyrosine kinase inhibitors in particular situations]Elisabeth Quoix
Lancet (London, England)|December 17, 2016
Programmed death of chemotherapy in non-small-cell lung cancer?Charlotte Leduc, Elisabeth Quoix
Pageof 12